Last Updated: July 14, 2026

Suppliers and packagers for baxfendy


✉ Email this page to a colleague

« Back to Dashboard


baxfendy

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Astrazeneca Ab BAXFENDY baxdrostat TABLET;ORAL 219878 NDA AstraZeneca Pharmaceuticals LP 0310-6001-30 30 TABLET, FILM COATED in 1 BOTTLE (0310-6001-30) 2026-05-15
Astrazeneca Ab BAXFENDY baxdrostat TABLET;ORAL 219878 NDA AstraZeneca Pharmaceuticals LP 0310-6001-95 7 TABLET, FILM COATED in 1 BOTTLE (0310-6001-95) 2026-05-15
Astrazeneca Ab BAXFENDY baxdrostat TABLET;ORAL 219878 NDA AstraZeneca Pharmaceuticals LP 0310-6002-30 30 TABLET, FILM COATED in 1 BOTTLE (0310-6002-30) 2026-05-15
Astrazeneca Ab BAXFENDY baxdrostat TABLET;ORAL 219878 NDA AstraZeneca Pharmaceuticals LP 0310-6002-95 7 TABLET, FILM COATED in 1 BOTTLE (0310-6002-95) 2026-05-15
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for baxfendy

Last updated: July 8, 2026

BAXFENDY Suppliers: Who Manufactures and Supplies the Drug (API, Fill-Finish, Packaging)

BAXFENDY supplier lists can only be produced from verified, drug-specific sources (FDA label/manufacturer section, NDA/BLA application references, Orange Book, inspection records, or documented commercial/contract manufacturing disclosures). No such drug-specific supplier, manufacturer, API, or fill-finish data is available in the information provided, and a complete and accurate supplier map cannot be generated.

Which companies supply BAXFENDY (API and finished dosage forms)?

No validated manufacturer or supplier data for BAXFENDY is available in the provided materials, so the set of companies supplying the API and the marketed finished product cannot be compiled.

What to look for on BAXFENDY labels to identify suppliers?

A supplier map is typically derived from the product’s prescribing information and package labeling “Manufactured for / Distributed by” lines, plus FDA listing entries that identify:

  • Drug substance (API) manufacturer
  • Finished dosage manufacturer (site-level)
  • Labeler/distributor
  • Strength and dosage form (to match the correct commercial configuration)

Do BAXFENDY suppliers differ by dosage strength or presentation?

A supplier map is often site- and presentation-specific, but no dosage-form or label-level supplier identifiers for BAXFENDY are available here.

What does the FDA “Orange Book” list for BAXFENDY manufacturers and labelers?

No Orange Book listing details for BAXFENDY are provided, so labeler/manufacturer entries and site information cannot be extracted.

Is BAXFENDY an NDA, ANDA, or BLA product with separate supplier records?

No FDA application type or listing record for BAXFENDY is provided, so supplier differentiation across application types cannot be determined.

What contract manufacturing organizations (CMOs) support BAXFENDY fill-finish?

No fill-finish or CMO references tied to BAXFENDY are available in the provided information.

How do fill-finish suppliers typically show up for commercial drug products?

When available, fill-finish suppliers are identified via:

  • “Manufactured by” and “Distributed by” statements on the label
  • FDA facility registrations and inspectional history tied to the dosage form
  • Filing references that cite listed manufacturing sites

Who supplies the BAXFENDY drug substance (API) and intermediates?

No drug substance supplier information for BAXFENDY is available in the provided information.

Are BAXFENDY APIs made by multiple sites (redundancy planning)?

A multi-site API strategy can exist, but there is no BAXFENDY-specific evidence provided to establish redundancy.

How can BAXFENDY supply chains be mapped using FDA inspections and facility registrations?

No facility-level inspection or registration data for BAXFENDY is available in the provided information, so a mapping to manufacturing sites cannot be produced.

What is the supplier risk profile for BAXFENDY (single-site dependence, capacity constraints)?

No supplier or site data for BAXFENDY is available here, so risk profiling based on redundancy and capacity cannot be completed.

Key Takeaways

  • A BAXFENDY supplier list requires verified drug-specific sources (FDA label/manufacturer section, Orange Book listing, facility registrations/inspections, or documented commercial disclosures).
  • No such BAXFENDY-specific supplier information is available in the provided inputs.
  • A complete, accurate supplier map cannot be produced.

FAQs

  1. How do I find the BAXFENDY API manufacturer name?
    From the prescribing information “Manufactured for” and “Manufactured by” sections and the associated FDA product listing, matched by strength and dosage form.

  2. Where do CMO fill-finish suppliers for BAXFENDY usually appear?
    In the drug label manufacturing statements and FDA facility registrations tied to the finished dosage form.

  3. Does BAXFENDY have different suppliers for different strengths?
    Often yes, but it must be confirmed by the label and FDA listing for each strength/presentation.

  4. Can Orange Book entries identify BAXFENDY manufacturers?
    Orange Book entries can identify labelers and listed drug information; site-level detail depends on the listing record.

  5. How do I validate whether a supplier is the true commercial manufacturer?
    Validate against the current package labeling “Manufactured by/for” text and FDA listing tied to the commercial product.

References

(No sources were provided that contain BAXFENDY-specific supplier/manufacturer data.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.